Dr. Maria H Alboszta, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 445 Clinic Dr, Morehead, KY 40351 Phone: 606-783-6805 Fax: 606-783-6869 |
Kristen Owen Kusterer, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 445 Clinic Dr, Morehead, KY 40351 Phone: 606-783-6805 Fax: 606-783-6869 |
Daniel On-fai Lee, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-780-5512 |
Marc Cruser, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 445 Clinic Dr, Morehead, KY 40351 Phone: 606-783-6805 Fax: 606-783-6869 |
News Archive
A new study funded by the National Cancer Institute reports that social support and other behavioral factors are related to levels of a circulating protein, which at high levels is associated with a poor prognosis in advanced ovarian cancer.
Certain physician characteristics and practice-setting characteristics are associated with Medicare beneficiaries receiving routine preventive services below the national goals, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
Queen's University and NUI Galway and are leading a clinical trial to investigate the possibility that statins, a drug commonly used to combat cholesterol, might help patients with acute severe respiratory failure.
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.
› Verified 7 days ago